Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: Premier who wrote (707)	1/3/1998 5:05:00 PM
From: jeffbas	Read Replies (1) \| Respond to of 2068

Note Bob Stovall one of the yearend show panelists on Friday's Wall Street Week had Oxford on his buy list. Good news for very short term price action.

To: Premier who wrote (707)	1/4/1998 12:40:00 AM
From: Michael Burry	Respond to of 2068

If OXHP can increase enrollment and hence revenues out of proportion to any increase in the MLR, then the current balance sheet and operations may allow OXHP to ride out the storm. It is a mistake to think cost pressures are only on the Medicare side, however, and significant MLR increases are a major risk as OXHP faces reality for the first time this year. Takeover would likely be for the next step in managed care - national coverage. Who would do this? Would-be suitors Aetna, Pacificare still have indigestion from recent acquisitions. Aetna is certainly not in danger and will be around. Given its depressed price it must be considered if one feels HMOs will rise again. It is also a good candidate for first to nat'l cover. HMO mergers out of necessity are friendly, and whether management would accept an outright takeover at prices less than $30 is debatable. For these reasons my position is neutral. I still feel no significant challenge to my Dec 10th post has arisen,a and that those numbers and concerns are still valid. Given the number and content of my posts here,I'm signing off. For disclosure I had purchased 700 shares at avg $23 and sold at $17, and have been on the sidelines for over 3 weeks now. I view the loss as a normal risk of investing and wonder whether the lawsuits are even valid despite questions re: management's intentions. Most of us that got in at the mid 20's as part of a diversified portfolio may even welcome the tax loss given the way the year has gone. Recent questions re: my integrity caught me by surprise, but unfortunately on SI there is no defense against a persistent attack. I welcome e-mail. Mike